A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.

Clinical trial NCT06473519 · COMPLETED

Trial details

NCT number: NCT06473519
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2024-06-24
Primary completion: 2024-09-20
Enrollment: 453

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.